Capital expenditure increased 31.0%
Capital expenditure changed +31.0% from the comparable as-filed period. The change ranks at the 33th percentile of 6 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Capital expenditure changed +31.0% from the comparable as-filed period. The change ranks at the 33th percentile of 6 prior comparable changes.
Cash & equivalents changed +22.4% from the comparable as-filed period.
Free-cash-flow proxy changed +38.1% from the comparable as-filed period. The change ranks at the 33th percentile of 6 prior comparable changes.
Operating cash flow changed +160.4% from the comparable as-filed period. The change ranks at the 83th percentile of 6 prior comparable changes.
Operating income changed -22.9% from the comparable as-filed period.
Operating margin changed -171 basis points from the comparable as-filed period.
Selling, general & administrative changed +21.2% from the comparable as-filed period.
Stock-based compensation changed -21.7% from the comparable as-filed period. The change ranks at the 50th percentile of 6 prior comparable changes.
Revenue changed +6.7% from the comparable as-filed period.
Capex / revenue changed +75 basis points from the comparable as-filed period.
Inventory changed -5.6% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.